Press Release: Global Ataxia Advocacy Organizations Unite to Host Largest International Congress for Ataxia Research in Atlanta
Research
News|Nov 9 2026
Press Release: Larimar Therapeutics Completes Rolling BLA Submission Seeking Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
Industry News
News|Nov 4 2026
Community Statement: Solid Biosciences
Industry News
News|Oct 26 2026
Press Release: Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia
Industry News
News|Oct 13 2026
Webinar Recording: Lexeo Therapeutics September 2026
FARA News | Industry News
News|Oct 7 2026
October 2026 – Advocacy Newsletter
Advocacy
News|Oct 7 2026
Community Statement: Neurocrine Biosciences announces the first clinical study of NBIB-223 (the FACET™ study), An investigational gene therapy for FA
Industry News
News|Sep 24 2026
Press Release & Community Statement: Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations
Industry News
News|Sep 17 2026
FARA Marks 18 Years of Empowering Athletes Through the Ataxian Athlete Initiative (AAI)
rideATAXIA
News|Sep 12 2026
September 2026 – Advocacy Newsletter
Advocacy
News|Aug 25 2026
FA Community Conversations – FDA’s Accelerated Approval Pathway: Recording Available on YouTube